Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-036517)

Filing Details

Accession Number:: 0001209191-18-036517
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-06-07 19:40:27
Reporting Period:: 2018-06-05

Accepted Time:: 2018-06-07 19:40:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
906709	Nektar Therapeutics	NKTR	Pharmaceutical Preparations (2834)	943134940

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
936728	A Roy Whitfield	C/O Nektar Therapeutics 455 Mission Bay Boulevard South San Francisco CA 94158		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-06-05	1,600	$55.22	173,600	No	4	P	Direct
Common Stock	Acquisiton	2018-06-06	2,000	$59.07	175,600	No	4	P	Direct
Common Stock	Acquisiton	2018-06-06	1,400	$59.80	177,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	20,000	Indirect	by Family Trust